<H1>Chapter DOI: 10.1007/s00105-014-3572-y<br/>Cited-By Count: 0</H1><table border="1" width="30%"><tr><td>Total References</td><td>26</td></tr><tr><td>Springer references</td><td>3</td></tr><tr><td>Non Springer references</td><td>23</td></tr><tr><td>BibStructured Count</td><td width="10%">24</td></tr><tr><td>BibUnstructured Count</td><td width="10%">2</td></tr><tr><td>DOI already available in SpringerLink</td><td>16</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>3</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>2</td></tr><tr><td>DOI Obtained For Non Springer</td><td>1</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>2</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>1</td></tr><tr><td>Valid DOI Enriched</td><td>1</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibBook</td><td>Dobbelstein T, Renzing O (2009) Die Verbesserung der Arzt-Patienten-Beziehung. VDM Verlag Dr. M&#252;ller, Saarbr&#252;cken</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Carruthers J; Botox Consensus Group (2004) Aesthetic considerations. In: Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plas Reconstr Surg 114(6 Suppl):1S&#8211;22S</td><td><a href=http://dx.doi.org/10.1097/01.PRS.0000144795.76040.D3>10.1097/01.PRS.0000144795.76040.D3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Imhof</span> <span style='background:#DDDDDD'>M</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Podda</span> <span style='background:#DDDDDD'>M</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Sommer</span> <span style='background:#DDDDDD'>B</span></span></aug> (<span style='background:#66FF66'>2013</span>) <span style='background:#FFD9B3'>&#196;sthetische Botulinumtoxin-Therapie</span> . Leitlinie der Deutschen Dermatologischen Gesellschaft (DDG), Deutschen Gesellschaft f&#252;r Dermatochirurgie (DGDC), Deutschen Gesellschaft f&#252;r &#196;sthetische Botulinumtoxin-Therapie (DGBT). AWMF Register-Nr. 013&#8211;077; <span style='background:#FF3300'>www.awmf.org/leitlinien/detail/ll/013-077.html</span></td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Kane M, Donofrio L, Ascher B, Hexsel D, Monheit G, Rzany B, Weiss R (2010) Expanding the use of neurotoxins in facial aesthetics: a 10 panel&#8217;s assessment and recommendations. J Drugs Dermatol 9(Suppl 1):1&#8211;25</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Philipp-Dormston WG, Bergfeld D, Sommer B; die Onabotulinumtoxin-Konsensusgruppe (2013) Konsensusempfehlungen zur Behandlung mit Onabotulinumtoxin A in der &#228;sthetischen Medizin. JDDG 11(Suppl. 1):1&#8211;42</td><td><a href=http://dx.doi.org/10.1111/ddg.12016>10.1111/ddg.12016</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Raspaldo H, Baspeyras M, Bellity P, Dallara JM, Gassia V, Niforos FR, Belhaouari L; Consensus Group (2011) Upper- and mid-face anti-aging treatment and prevention using onabotulinumtoxin A: the 2010 multidisciplinary French consensus &#8211; part 1. J Cosmet Dermatol 10:36&#8211;50</td><td><a href=http://dx.doi.org/10.1111/j.1473-2165.2010.00544.x>10.1111/j.1473-2165.2010.00544.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Raspaldo H, Niforos FR, Gassia V, Dallara JM, Bellity P, Baspeyras M, Belhaouari L; Consensus Group (2011) Lower-face and neck antiaging treatment and prevention using onabotulinumtoxin A: the 2010 multidisciplinary French consensus &#8211; part 2. J Cosmet Dermatol 10:131&#8211;149</td><td><a href=http://dx.doi.org/10.1111/j.1473-2165.2011.00560.x>10.1111/j.1473-2165.2011.00560.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Rzany B, Fratila AA, Fischer TC, Hilton S, Pavicic T, Rothhaar A, Sattler G, Sommer B, Pickett A (2013) Recommendations for the best possible use of botulinum neurotoxin type a (speywood units) for aesthetic applications. J Drugs Dermatol 12:80&#8211;84</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR9</td><td>BibArticle</td><td>De Boulle K (2008) Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids. J Cosmet Laser Ther 10:87&#8211;92</td><td><a href=http://dx.doi.org/10.1080/14764170701854679>10.1080/14764170701854679</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>De Boulle K, Fagien S, Sommer B, Glogau R (2010) Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction. Clin Interv Aging 5:101&#8211;118</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR11</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Sommer</span> <span style='background:#DDDDDD'>B</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Zschocke</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Bergfeld</span> <span style='background:#DDDDDD'>D</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Sattler</span> <span style='background:#DDDDDD'>G</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Augustin</span> <span style='background:#DDDDDD'>M</span></span></aug> (<span style='background:#66FF66'>2003</span>) <span style='background:#CCCCFF'>Satisfaction of patients after treatment with botulinum toxin for dynamic facial lines</span>. <span style='background:#CCFF99'>Dermatol Surg</span> <span style='background:#FFCC66'>29</span>:<span style='background:#D279FF'>456&#8211;460</span></td><td><a href=http://dx.doi.org/10.1097/00042728-200305000-00004>10.1097/00042728-200305000-00004</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, Year, FirstPage, Author_FamilyName_2, ArticleTitle, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Grimes PE (2007) Facial aesthetics and the importance of patient satisfaction. Cosmet Dermatol 20(7 Suppl 3):4&#8211;7</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Habbema L (2004) Facial esthetics and patient selection. Clin Dermatol 22:14&#8211;17</td><td><a href=http://dx.doi.org/10.1016/j.clindermatol.2003.12.032>10.1016/j.clindermatol.2003.12.032</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Poulos GA, Brodell RT, Mostow EN (2008) Improving quality and patient satisfaction in dermatology office practice (research letter). Arch Dermatol 144:263&#8211;265</td><td><a href=http://dx.doi.org/10.1001/archdermatol.2007.58>10.1001/archdermatol.2007.58</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibChapter</td><td>Kreyden OP (2012) Wie behandle ich Patienten, damit sie maximal unzufrieden sind: Lernen durch Perspektiven-Wechsel. In: Ruzicka T, Wolff H, Thomas P, Prinz J (Hrsg) Fortschritte der praktischen Dermatologie und Venerologie. Springer, Berlin, S&nbsp;364&#8211;369</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1007/978-3-540-77148-7>10.1007/978-3-540-77148-7</a></td><td><b>CrossRef-Meta</b></td>
<td>BookTitle</td><td>CrossRef</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Kirsner RS, Federman DG (1997) Patient satisfaction: quality of care from the patients&#8217; perspective. Arch Dermatol 133:1427&#8211;1431</td><td><a href=http://dx.doi.org/10.1001/archderm.1997.03890470105017>10.1001/archderm.1997.03890470105017</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibBook</td><td>Thill K-D (2008) Patientenzufriedenheit in der Arztpraxis. Deutscher &#196;rzte-Verlag, K&#246;ln</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR18</td><td>BibChapter</td><td>Kreyden OP (2010) Der Patient als Herausforderung. &#220;ber den Umgang mit schwierigen Patienten in der &#196;sthetik. In: Ruzicka T, Wolff H, Thomas P, Prinz J (Hrsg) Fortschritte der praktischen Dermatologie und Venerologie. Springer, Berlin, S&nbsp;323&#8211;329</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1007/978-3-540-77148-7>10.1007/978-3-540-77148-7</a></td><td><b>CrossRef-Meta</b></td>
<td>BookTitle</td><td>CrossRef</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Carruthers J, Carruthers A (2007) Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes. Dermatol Surg 33:10&#8211;17</td><td><a href=http://dx.doi.org/10.1111/j.1524-4725.2006.32326.x>10.1111/j.1524-4725.2006.32326.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Fagien S, Carruthers JD (2008) A comprehensive review of patient-reported satisfaction with botulinum toxin type a for aesthetic procedures. Plast Reconstr Surg 122:1915&#8211;1925</td><td><a href=http://dx.doi.org/10.1097/PRS.0b013e31818dbfe3>10.1097/PRS.0b013e31818dbfe3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Rzany B, Ascher B, Monheit G (2010) Treatment of glabellar lines with botulinum toxin type A (Speywood Unit): a clinical overview. J Eur Acad Dermatol Venereol 24(Suppl 1):1&#8211;14</td><td><a href=http://dx.doi.org/10.1111/j.1468-3083.2009.03475.x>10.1111/j.1468-3083.2009.03475.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Sepehr A, Chauhan N, Alexander AJ, Adamson PA (2010) Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction. Aesthetic Plast Surg 34:583&#8211;586</td><td><a href=http://dx.doi.org/10.1007/s00266-010-9511-0>10.1007/s00266-010-9511-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Carruthers A, Cohen JL, Cox SE, De Boulle K, Fagien S, Finn CJ, Flynn T, Lowe NJ, Raspaldo H, Sommer B, de Almeida AT (2007) Facial aesthetics: achieving the natural, relaxed look. J Cosmet Laser Ther 9(Suppl 1):6&#8211;10</td><td><a href=http://dx.doi.org/10.1080/17429590701523927>10.1080/17429590701523927</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Cox SE, Finn JC (2005) Social implications of hyperdynamic facial lines and patient satisfaction outcomes. Int Ophtalm Clin 45:13&#8211;24</td><td><a href=http://dx.doi.org/10.1097/01.iio.0000167237.49396.7b>10.1097/01.iio.0000167237.49396.7b</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Finn JC, Cox SE, Earl ML (2003) Social implications of hyperfunctional facial lines. Dermatol Surg 29:450&#8211;455</td><td><a href=http://dx.doi.org/10.1097/00042728-200305000-00003>10.1097/00042728-200305000-00003</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Lewis MB, Bowler PJ (2009) Botulinum toxin cosmetic therapy correlates with a more positive mood. J Cosmet Dermatol 8:24&#8211;26</td><td><a href=http://dx.doi.org/10.1111/j.1473-2165.2009.00419.x>10.1111/j.1473-2165.2009.00419.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>